...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >An electrochemical signal-on apta-cyto-sensor for quantitation of circulating human MDA-MB-231 breast cancer cells by transduction of electro-deposited non-spherical nanoparticles of gold
【24h】

An electrochemical signal-on apta-cyto-sensor for quantitation of circulating human MDA-MB-231 breast cancer cells by transduction of electro-deposited non-spherical nanoparticles of gold

机译:用于通过转导通过转导循环人MDA-MB-231乳腺癌细胞的电化学信号 - Cyta传感器,通过转导电沉积的非球形纳米颗粒

获取原文
获取原文并翻译 | 示例

摘要

A highly simple, sensitive, specific and low-cost electrochemical apta-cyto-sensor for determination of circulating human MDA-MB-231 breast cancer cells was fabricated. Non-spherical nanoparticles of gold were electro-deposited in the presence of ethosuximide as a shape directing and size controlling agent. The nanoparticles had dimensions ranging 50-150 nm, and covered the underlying surface with a roughness factor of 8.03. The Non-spherical nanoparticles were then employed as the apta-cyto-sensor transducer. A 83-mer DNA aptamer that is specific to capturing the cell surface proteins was immobilized on the transducer surface, and binding with the cells was followed using the ferro/ferricyanide redox marker. The aptamer was immobilized within similar to 200 min on the transducer surface. The cells were quantified with an equation of regression of Delta Ip(mu A) = (1.028 +/- 0.027) log (C (cell mL(-1))) + (0.2199 +/- 0.0944), a sensitivity of 1.028 mu A (log (concentration / cell rnL(-1)))(-1) and a quantitation limit of 2 cell mL(-1), in a concentration range of 5 to 2 x 10(6) cell mL(-1). The apta-cyto-sensor selectivity was also evaluated toward AsPC-1, Calu-6, HeLa, MCF-7 and melanoma B16/F10 cell lines. The apta-cyto-sensor had a fabrication reproducibility of 4.2%, regeneration capability of 5.1%, a stability of 35 days, and a potential application for the detection of MDA-MB-231 cells in the spiked blood serum samples with a sensitivity of 0.8975 mu A (log (concentration / cell mL(-1)))(-1) and a quantitation limit of 5 cell mL(-1), in a concentration range of 10 to 1 x 10( 3) cell mL(-1). The apta-cyto-sensor would be applicable for breast cancer diagnosis at early stage. (C) 2019 Published by Elsevier B.V.
机译:制造了一种高度简单,敏感,特异性和低成本的电化学APTA-CYTO传感器,用于测定循环人MDA-MB-231乳腺癌细胞。金属纳米颗粒在乙氧酰亚胺存在下被电沉积作为形状引导和尺寸控制剂。纳米颗粒具有50-150nm的尺寸,并覆盖下面的表面,粗糙度为8.03。然后采用非球形纳米颗粒作为APTA-Cyton传感器换能器。将特定于捕获细胞表面蛋白质的83-MEL DNA适体固定在换能器表面上,并使用铁/铁氰化物氧化还原标志物随后与细胞结合。在换能器表面上固定适体固定到200分钟的内。用Delta IP(MU A)=(1.028 +/- 0.027)对数(C(Cell ml(-1)))+(0.2199 +/- 0.0944),敏感性为1.028亩A(浓度/电池RN1(-1)))( - 1)和2个细胞m1(-1)的定量限,浓度范围为5-2×10(6)细胞m1(-1) 。还向ASPC-1,Calu-6,HeLa,MCF-7和黑色素瘤B16 / F10细胞系评估了APTA-Cyto-Sensor选择性。 APTA-Cyto-Sensor的制备再现性为4.2%,再生能力为5.1%,稳定性为35天,以及检测尖刺血清样品中MDA-MB-231细胞的潜在应用,具有灵敏度0.8975μA(浓度/细胞m1))(-1))( - 1)和5个细胞m1(-1)的定量限,浓度范围为10-1×10(3)克( - 1)。 APTA-Cyto-Sensor适用于早期乳腺癌诊断。 (c)2019年由elestvier b.v发布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号